<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">A meta-analysis study conducted by 
 <xref rid="bib27" ref-type="bibr">Li et al. (2020a)</xref>, summarized the proportion of cardiovascular disease (16.4%), diabetes (9.7%), and hypertension (17.1%) in COVID-19 patients. They concluded that patients with previous cardiovascular diseases may have an increased risk of developing severe conditions, while, COVID-19 infection can exacerbate the damage of the heart. In COVID-19 patients with underlying cardiovascular disease, hypersensitive C-reactive protein, and serum creatinine levels were elevated compared with COVID-19 patients with no underlying cardiovascular disease. Overall these indications suggest that COVID-19 can affect cardiovascular function and lead to myocardial injury (
 <xref rid="bib8" ref-type="bibr">Chen et al., 2020a</xref>).
</p>
